Skye Bioscience, Inc. (SKYE)

0.7204 -0.02 (-2.38%) USD  |  NASDAQ  |  Mar 06, 16:00
0.7345 +0.01 (+1.96%) Pre-Market: 20:00
More

Skye Bioscience Commercial Paper Liability (Annual Per Share)

Commercial Paper Liability (Annual Per Share) Chart

View Commercial Paper Liability (Annual Per Share) for SKYE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Commercial Paper Liability (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Commercial Paper Liability (Annual Per Share) Range, Past 5 Years

View Commercial Paper Liability (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Commercial Paper Liability (Annual Per Share) Benchmarks

View Commercial Paper Liability (Annual Per Share) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. --
Merck & Co., Inc. --
ACADIA Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. --
Savara, Inc. --